Thrombosis and Hemostasis Research
Thrombosis is a crucial hemostatic process for maintaining blood volume (hemostasis) following injury, yet aberrant thrombosis can trigger pathological conditions including myocardial infarction and stroke. Therefore the initiation of thrombosis is tightly controlled under physiological conditions.
Thrombosis and Hemostasis Research Products Targets
- PI 3-kinase (22)
- Cell Adhesion Molecule (21)
- Others (7)
- Cyclooxygenase (24)
- PPARγ (16)
- PPARδ (5)
- PPARα (7)
- NK2 Receptor (7)
- NK1 Receptor (15)
- NK3 Receptor (5)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- NO donors and precursors (9)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Purinergic (P2Y) Receptor (31)
- Protease-Activated Receptor (23)
- Phospholipase (16)
- Prostanoid Receptor (24)
- Phosphodiesterase (34)
Products for Thrombosis and Hemostasis Research - Page 23
- Cat.No. Product Name Information/Activity
-
BCC6092
AR-C 102222
253771-21-0
-
BCC7506
BYK 191023 dihydrochloride
Potent and selective inhibitor of iNOS
-
BCC6824
EIT hydrobromide
1071-37-0
-
BCC6862
2-Iminopiperidine hydrochloride
16011-96-4
-
BCC6837
S-Isopropylisothiourea hydrobromide
4269-97-0
-
BCC6791
(S)-Methylisothiourea sulfate
867-44-7
-
BCC5706
L-NIL hydrochloride
150403-89-7
-
BCC7057
1400W dihydrochloride
1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM.
-
BCC7647
ARL 17477 dihydrochloride
866914-87-6
-
BCC6770
3-Bromo-7-nitroindazole
3-Bromo-7-nitroindazole is a more potent and selective inhibitor of neuronal nitric oxide synthase (nNOS) than eNOS or inducible nitric oxide synthase (iNOS). 3-Bromo-7-nitroindazole affects the intercellular messenger nitric oxide (NO) synthesis throughout the body and brain.
